Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 170

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Cell-based therapeutic strategies for multiple sclerosis

Open access
Scolding, Neil J, Pasquini, Marcelo, Reingold, Stephen C, Cohen, Jeffrey A, International Conference on Cell-Based Therapies for Multiple Sclerosis:, Atkins, Harold, Banwell, Brenda, Bar-Or, Amit, Bebo, Bruce, Bowen, James, Burt, Richard, Calabresi, Peter, Cohen, Jeffrey, Comi, Giancarlo, Connick, Peter, Cross, Anne, Cutter, Gary, Derfuss, Tobias, Ffrench-Constant, Charles, Freedman, Mark, Galipeau, Jacques, Goldman, Myla, Goldman, Steven, Goodman, Andrew, Green, Ari, Griffith, Linda, Hartung, Hans-Peter, Hemmer, Bernhard, Hyun, Insoo, Iacobaeus, Ellen, Inglese, Matilde, Jubelt, Burk, Karussis, Dimitrios, Küry, Patrick, Landsman, Douglas, Laule, Cornelia, Liblau, Roland, Mancardi, Giovanni, Ann Marrie, Ruth, Miller, Aaron, Miller, Robert, Miller, David, Mowry, Ellen, Muraro, Paolo, Nash, Richard, Ontaneda, Daniel, Pasquini, Marcelo, Pelletier, Daniel, Peruzzotti-Jametti, Luca, Pluchino, Stefano, Racke, Michael, Reingold, Stephen, Rice, Claire, Ringdén, Olle, Rovira, Alex, Saccardi, Riccardo, Sadiq, Saud, Sarantopoulos, Stefanie, Savitz, Sean, Scolding, Neil, Soelberg Sorensen, Per, Pia Sormani, Maria, Stuve, Olaf, Tesar, Paul, Thompson, Alan, Trojano, Maria, Uccelli, Antonio, Uitdehaag, Bernard, Utz, Ursula, Vukusic, Sandra, Waubant, Emmanuelle, Wilkins, Alastair · 2017 · Brain

Abstract

The availability of multiple disease-modifying medications with regulatory approval to treat multiple sclerosis illustrates the substantial progress made in therapy of the disease. However, all are only partially effective in preventing inflammatory tissue damage in the central nervous system and none directly promotes repair. Cell-based therapies, including immunoablation followed by autologous haematopoietic stem cell transplantation, mesenchymal and related stem cell transplantation, pharmacologic manipulation of endogenous stem cells to enhance their reparative capabilities, and transplantation of oligodendrocyte progenitor cells, have generated substantial interest as novel therapeutic strategies for immune modulation, neuroprotection, or repair of the damaged central nervous system in multiple sclerosis. Each approach has potential advantages but also safety concerns and unresolved questions. Moreover, clinical trials of cell-based therapies present several unique methodological and ethical issues. We summarize here the status of cell-based therapies to treat multiple sclerosis and make consensus recommendations for future research and clinical trials.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/brain/awx154

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 170

Metadata

Authors
Scolding, N. J., Pasquini, M., Reingold, S. C., Cohen, J. A., Sclerosis:, I. C. O. C.-B. T. F. M., Atkins, H., Banwell, B., Bar-Or, A., Bebo, B., Bowen, J., Burt, R., Calabresi, P., Cohen, J., Comi, G., Connick, P., Cross, A., Cutter, G., Derfuss, T., Ffrench-Constant, C., Freedman, M., Galipeau, J., Goldman, M., Goldman, S., Goodman, A., Green, A., Griffith, L., Hartung, H.-P., Hemmer, B., Hyun, I., Iacobaeus, E., Inglese, M., Jubelt, B., Karussis, D., Küry, P., Landsman, D., Laule, C., Liblau, R., Mancardi, G., Ann Marrie, R., Miller, A., Miller, R., Miller, D., Mowry, E., Muraro, P., Nash, R., Ontaneda, D., Pasquini, M., Pelletier, D., Peruzzotti-Jametti, L., Pluchino, S., Racke, M., Reingold, S., Rice, C., Ringdén, O., Rovira, A., Saccardi, R., Sadiq, S., Sarantopoulos, S., Savitz, S., Scolding, N., Soelberg Sorensen, P., Pia Sormani, M., Stuve, O., Tesar, P., Thompson, A., Trojano, M., Uccelli, A., Uitdehaag, B., Utz, U., Vukusic, S., Waubant, E., & Wilkins, A.
Venue
Brain
Published
2017-07-21
Volume
140
Issue
11
Pages
2776-2796
ISSN
  • 0006-8950 (ISSN-L)
  • 1460-2156
OpenAlex
W2185110053
Cited by
170
References
19
FWCI
16.50
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.